Molecular Characterization of Achromobacter Isolates from Cystic Fibrosis and Non-Cystic Fibrosis Patients in Madrid, Spain

Innate Aminoglycoside Resistance of Achromobacter xylosoxidans Is Due to AxyXY-OprZ, an RND-Type Multidrug Efflux Pump

(2012) Julien Bador et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Multilocus Sequence Typing Scheme Implies Population Structure and Reveals Several Putative Novel Achromobacter Species

(2012) T. Spilker et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Multilocus Sequence Analysis of Isolates of Achromobacter from Patients with Cystic Fibrosis Reveals Infecting Species Other than Achromobacter xylosoxidans

(2012) W. Ridderberg et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Identification of Achromobacter xylosoxidans by detection of the blaOXA-114-like gene intrinsic in this species

(2011) Jane F. Turton et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients

(2011) A. Lambiase et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Achromobacter xylosoxidans: Characterization of Strains in Brazilian Cystic Fibrosis Patients

(2011) R. H. V. Pereira et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The Changing Microbial Epidemiology in Cystic Fibrosis

(2010) J. J. LiPuma   CLINICAL MICROBIOLOGY REVIEWS

Respiratory Microbiology of Patients With Cystic Fibrosis in the United States, 1995 to 2005

(2009) Samiya Razvi et al.   CHEST

Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients

(2009) C.R. Hansen et al.   Journal of Cystic Fibrosis

Characterization of a Naturally Occurring Class D  -Lactamase from Achromobacter xylosoxidans

(2008) Y. Doi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Achromobacter xylosoxidansrespiratory tract infections in cystic fibrosis patients 

(2008) TIZIANA RASO et al.   APMIS